8000816688
Investors
Close
Lost Password
  • Blog
  • Install App
  • Ask The Analyst
EquityPandit
  • ios
  • Home
  • Get Started
  • Pricing
  • Payment Option
  • Prima
  • Performance
  • Latest News
  • Technical Analysis
    • Stock Market
    • Commodity Market
  • Live Messenger
  • Tutorials
  • Media
  • Contact Us
  • Home
  • Get Started
  • Pricing
  • Payment Option
  • Prima
  • Performance
  • Latest News
  • Technical Analysis
    • Stock Market
    • Commodity Market
  • Live Messenger
  • Tutorials
  • Media
  • Recommendation
  • Contact Us

Rossari Biotech IPO Subscribed 60% on First Day

July 13, 2020 at 7:23 PM EquityPandit
IPO_EP

The initial public offer (IPO) of Rossari Biotech Ltd on Monday was subscribed 60% on the first day of the offering. Rossari Biotech has set a price band of Rs 423-425 per share. The IPO closes on 15 July. The company plans to raise Rs 50 crore through the IPO, while promoters are selling shares worth Rs446 crore.

As per stock exchange data, the portion of shares reserved for institutional investors has subscribed 41 per cent, while shares reserved for non-institutional investors or HNIs saw subscription of 11 per cent. The retail quota was subscribed 92 per cent.

Rossari Biotech is a manufacturer of speciality chemicals. It provides customized solutions to the apparel, animal & poultry feed, and FMCG industries by offering a diversified product portfolio and operates in 18 countries including India, Bangladesh, Vietnam, and Mauritius.

Motilal Oswal in an IPO report said “The company has delivered robust growth in revenue/EBITDA/PAT over FY2015-FY2020, reporting CAGRs of 31%/51%/78%, leading to high return ratios (RoE/RoCE at 25%/32% in FY2020). The new capacity expansion at Dahej (132ktpa) should strengthen its portfolio in the high-growth HPPC segment to serve its wide customer base. Customized product offering, fungible capacities and rapid finished product conversion rate remain the key differentiators for the company. At the upper price band of Rs425, the stock is available at 33 times FY2020 earnings”.

Rossari Biotech is the first IPO to hit the Indian markets since SBI Cards and Payments Services Ltd raised over Rs10,000 crore in early March. Investment banks Axis Capital and ICICI Securities are managing the IPO.

Read EquityPandit’s Nifty Outlook for the Week

. Investment banks Axis Capitaland MauritiusBangladeshICICI Securitiesindiainitial public offer (IPO)Rossari BiotechRossari Biotech LtdVietnam

Post navigation

Previous PostNext Post

Register To Get 95% Accurate Tips For Free, Through SMS


I accept Terms and Condition

Recent News

equitypandit UCO Bank Reports Q3 Net Profit of Rs 35.44 Crore

January 25, 2021 AT 3:32 PM

equitypandit WEF’s Davos Summit Begins; Modi to Address on Thursday

January 25, 2021 AT 1:14 PM

equitypandit Ultratech Cement Rises 2% On Doubling In Q3 Net Profit

January 25, 2021 AT 12:08 PM

equitypandit Voter IDs to go Digital from Today

January 25, 2021 AT 11:31 AM

I accept Terms and Condition



Download Now

PREMIUM SERVICES

EQUITY

COMMODITY

CURRENCY

EquityPandit in Media


has been Featured on

2
3
Nbc-logo
7
PRESS-TRUST-OF-INDIA
4
Zee_News_2011
6
telegraph
http://www.equitypandit.com/my-account/
  • Home
  • Terms and Conditions
  • About Us
  • Careers
  • Services
  • Contact Us
  • Daily Advices
  • Site Map
  • Latest News
  • Technical Analysis
  • Payment Option
  • Get Account Details
  • Pay Via NEFT
  • privacy Policy
  • Disclosure
  • Grievance Mechanism

An ISO 9001:2008 Certified Company

Copyright © 2014 EquityPandit Financial Services Pvt. Ltd.
All rights reserved.

A GROUP COMPANY

SEBI Registered Investment Advisor
SEBI Registration Number : INA000006688

Investment/Trading in markets is subject to market risk.